1353867-93-2
1353867-93-2
Chemical Structure
Triclabendazole-d3
Synonym(s): CGA89317-d3
- CAS No.: 1353867-93-2
- Formula:C14H6D3Cl3N2OS
- Molecular Weight:362.68
IUPAC Name: 5-chloro-6-(2,3-dichlorophenoxy)-2-((methyl-d3)thio)-1H-benzo[d]imidazole
InChIKey: NQPDXQQQCQDHHW-FIBGUPNXSA-N
SMILES: ClC1=C(C=C(NC(SC([2H])([2H])[2H])=N2)C2=C1)OC(C=CC=C3Cl)=C3Cl
Biological Activity: Triclabendazole-d3 is the deuterium labeled Triclabendazole (HY-B0621). Triclabendazole is an orally active parasite inhibitor. Triclabendazole has anti-Leishmania activity and induces gasdermin E (GSDME)-dependent pyroptosis by caspase-3 activation. Triclabendazole can be used for the research of fasciola hepatica[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Triclabendazole-d3 | Triclabendazole-d3 is the deuterium labeled Triclabendazole (HY-B0621). Triclabendazole is an orally active parasite inhibitor. Triclabendazole has anti-Leishmania activity and induces gasdermin E (GSDME)-dependent pyroptosis by caspase-3 activation. Triclabendazole can be used for the research of fasciola hepatica. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclabendazole (Standard) | 99.32% | Triclabendazole (Standard) is the analytical standard of Triclabendazole. This product is intended for research and analytical applications. Triclabendazole is an orally active parasite inhibitor. Triclabendazole has anti-Leishmania activity and induces gasdermin E (GSDME)-dependent pyroptosis by caspase-3 activation. Triclabendazole can be used for the research of fasciola hepatica. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclabendazole-13C,d3 | Triclabendazole-13C,d3 is the 13C- and deuterium labeled Triclabendazole. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Triclabendazole | 99.36% | Triclabendazole is an orally active parasite inhibitor. Triclabendazole has anti-Leishmania activity and induces gasdermin E (GSDME)-dependent pyroptosis by caspase-3 activation. Triclabendazole can be used for the research of fasciola hepatica. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
